Hosted by Founders in biotech · 🇺🇸 US · EN · 14 episodes
Established thought leaders with verified media credentials.
Sharing the founder’s journey and scientific achievements to inspire the leaders of tomorrow. On each episode, the host Serghei Glinca, biotech entrepreneur and ecosystem builder, meets unconventional founders to talk about science, entrepreneurship, fundraising, and leadership. The shared lessons of the founder’s journey show a clear path how to take action and activate talents to start their own journey as founders. Serghei and guests also discuss practical perspectives and tools to motivate the scientific community to turn science into tangible impact.
Founders in biotech hosts founders in biotech, a business show with 14 episodes published.
Marco De Vivo, is the head of the Molecular Modeling and Drug Discovery lab at the Italian Institute of Technology. He is also the Associate Director of the IIT, responsible for Computational Sciences. His research is fo
Maria Soloveychik is the co-founder and CEO of SyntheX, a therapeutics company accelerating drug discovery through synthetic biology. SyntheX, founded in 2016 and headquartered in San Francisco, advances its own oncology
Christoph Lengauer has contributed to the development of 10 FDA-approved cancer medicines. Christoph is Chief Scientific Officer and a co-founder of Curie.Bio, where he and his team co-pilot seed-stage companies to help
Business development is an essential process for biotech companies to build relationships with partners and create value from the deal structures that are based on science. We are taking a deep dive with James Lee into t
James Lee received his B.S and M.S. in Structural Biology from Seoul National University, he held various roles in research, research planning, and business development at LG Chem. In year 2000, James co-founded Crystal
Prof. Yaniv Erlich received his bachelor’s degree from Tel-Aviv University, Israel in 2006 and a PhD from the Watson School of Biological Sciences at Cold Spring Harbor Laboratory in 2010. Yaniv Erlich was an Associate P
Kiyoshi Takayama has received a Ph.D. in pharmaceutical science from the University of Tokyo. After his PhD he worked for more than 12 years as a research scientist at Taisho Pharmaceutical, Japan, where he was involved
David Younger is a bioengineer and started his biotech journey directly after his PhD. David’s scientific research was focused on the application of synthetic biology techniques for high-throughput screening of protein-p
The path from the lab bench to market in biotech has many hurdles and lots of opportunities. Sometimes too many. Elaine Hamm has experienced all stages of bringing innovation from academia to a successful company and pro
Targeted protein degradation, TPD, is a new and disruptive therapeutic approach for development of medicines. TPD opened doors to develop small molecules to drug the ‘undruggable’. Instead of blocking the function of a p
Targeted protein degradation, or TPD, is a new and disruptive therapeutic approach for development of medicines. TPD utilizes the design of small molecules that can address disease-causing proteins that are highly challe
Mark Tebbe started his career as an organic chemist and later had senior positions at Lilly. After 16 years of a successful career in pharma, Mark started his biotech journey. He has been leading drug discovery at multip
Carlo started his biotech journey as a founder and G7 Therapeutics as a spin-off from the University of Zurich. The company developed a technology for stabilization of G protein-coupled receptors (GPCRs), a superfamily o
As a founder, Serghei experienced the challenges of building a company in the fragmented biotech ecosystem. Giving back and connecting the biotech ecosystem has become his mission.
Sponsor detection runs nightly. Check back soon.
No public pitch examples yet for this show.
Generate your own personalised pitchBased on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:
Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
founders in biotech has a verified contact on file. Create a free PitchCentric account to access it and generate a personalised pitch in seconds. Research at least 3 recent episodes first and lead with a specific angle that serves their business audience.
founders in biotech is hosted by Founders in biotech. The show is categorised under business and has published 14 episodes.
founders in biotech has published 14 episodes.
founders in biotech regularly covers business. It sits in the business category.
founders in biotech is accessible for guests with genuine business expertise. A personalised, episode-aware pitch will still outperform a generic one every time.
founders in biotech hasn't explicitly signalled guest openness in recent episodes. That doesn't rule out pitching. your hook just needs to be especially compelling and relevant to their recent content.
Episodes of founders in biotech average 40 minutes. a focused format where a clear narrative arc and tight preparation matter most.
Our data rates founders in biotech's guest bar at 80/100 (Premium tier). Established thought leaders with verified media credentials. Sign in to PitchCentric to see how your own Pod Score compares against this show.
Methodology. Booking Probability™ blends Listen Score, 30-day Virality, open-to-guests detection, and Apple ratings. Data refreshed every 60 minutes. Listen Score and Booking Probability are calculated by PitchCentric. Last enriched 10 days ago.
